Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 1901)

Moscow, Moscow 115478

0 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) — Running, not enrolling